Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1990-11-21
1991-05-28
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
564165, A61K 4904, C07C23305
Patent
active
050193716
ABSTRACT:
The compound N-(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamido]-N'-methyl-2,4,6 -triiodoisophthalamide and similar such compounds may be used as x-ray contrast agents which are water-soluble, safe and in an aqueous solution are non-viscous. Methods of preparing N-(2,3-dihydroxypropyl)-5-[N-(2-hdyroxyethyl)glycolamido]-N'-methyl-2,4,6- triiodoisophthalamide are provided.
REFERENCES:
patent: 4021481 (1977-05-01), Almen et al.
patent: 4307072 (1981-12-01), Smith
patent: 4352788 (1982-10-01), Felder et al.
Lin Youlin
Wallace Rebecca A.
White David H.
Downard Rita E.
Klostermann Roy J.
Mallinckrodt Medical Inc.
Maples John S.
LandOfFree
Novel x-ray contrast agents, compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel x-ray contrast agents, compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel x-ray contrast agents, compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-35013